Biotech

All Articles

Innovent links cytokine to intestines cancer reactions

.Innovent Biologics has actually created the scenario that its checkpoint inhibitor-cytokine blend h...

Merck, Daiichi ADC attacks goal in period 3 bronchi cancer cells research study

.A phase 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina grows artificial intelligence concentrate along with collab to pick cancer cells aim ats

.Five months after Rakovina Therapies turned toward expert system, the cancer-focused biotech has pa...

Ascendis' dwarfism medication favorites in phase 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a possible danger to BioMarin's Voxzogo, disclosing period ...

Despite ph. 3 miss, Alkeus finds course ahead for eye condition property

.Though Alkeus Pharmaceuticals' oral eye condition property fell short to dramatically decrease geog...

Kairos goes public along with $6M IPO to fund tests of cancer cells medication

.Along with a triad of biotechs reaching the Nasdaq on Friday, it was actually very easy to overlook...

Vaccine and also Keytruda combo helpful in squamous tissue carcinoma

.Immune gate inhibitors are actually the superheroes of cancer therapy. Medicines like Bristol Myers...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootings as...

Regeneron's Opdualag opponent presents 57% feedback cost

.Regeneron is back along with long-lasting follow-up for its own LAG-3 inhibitor and also PD-1 preve...

AstraZeneca posts data on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has discussed a very early look at the performance of its own in-house antibody-drug co...